TLR9 Agonists Can Act as In-situ Anti-tumor Vaccines
Osteosarcoma (OS) is a highly malignant mesenchymal tumor composed of cells that produce bone-like and immature bone tissue. The peak incidence occurs in the second decade of life after birth. Although relativelyRead More…